NCT06232291View on ClinicalTrials.gov

Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression

CompletedOBSERVATIONAL

Enrollment

3

Participants

Timeline

Start Date

April 21, 2023

Primary Completion Date

May 24, 2024

Study Completion Date

May 24, 2024

Conditions

Treatment-Resistant DepressionMajor Depressive Disorder

Trial Locations (1)

80-214

Medical University of Gdańsk, Gdansk

Sponsors

Collaborators (1)

Perception Neuroscience

All Listed Sponsors

collaborator

Perception Neuroscience

INDUSTRY

lead

Medical University of Gdansk

OTHER